These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11914600)

  • 21. [Loss of heterozygosity of plasma circulating DNA from hepatocellular carcinoma patients and its clinical significance].
    Pang JZ; Qin LX; Wang QQ; Ren N; Sun BS; Lin GL; Ye QH; Liu YK; Tang ZY
    Zhonghua Gan Zang Bing Za Zhi; 2007 Dec; 15(12):906-9. PubMed ID: 18171524
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic classification of combined hepatocellular-cholangiocarcinoma.
    Fujii H; Zhu XG; Matsumoto T; Inagaki M; Tokusashi Y; Miyokawa N; Fukusato T; Uekusa T; Takagaki T; Kadowaki N; Shirai T
    Hum Pathol; 2000 Sep; 31(9):1011-7. PubMed ID: 11014564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 16q heterozygosity loss in Wilms' tumour in children and its clinical importance.
    Skotnicka-Klonowicz G; Rieske P; Bartkowiak J; Szymik-Kantorowicz S; Daszkiewicz P; Debiec-Rychter M
    Eur J Surg Oncol; 2000 Feb; 26(1):61-6. PubMed ID: 10718182
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.
    Sheu JC; Lin YW; Chou HC; Huang GT; Lee HS; Lin YH; Huang SY; Chen CH; Wang JT; Lee PH; Lin JT; Lu FJ; Chen DS
    Br J Cancer; 1999 May; 80(3-4):468-76. PubMed ID: 10408855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of minimal regions of deletion at 8p23.1-22 associated with metastasis of hepatocellular carcinoma.
    Lu T; Hano H
    Liver Int; 2007 Aug; 27(6):782-90. PubMed ID: 17617121
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma.
    Zainuddin N; Jaafart H; Isa MN; Abdullah JM
    Neurol Res; 2004 Jan; 26(1):88-92. PubMed ID: 14977064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Loss of heterozygosity on chromosomes 17 and 16 in primary hepatocellular carcinomas].
    Shao J; Li X; Liu Z
    Zhonghua Yi Xue Za Zhi; 1999 Jun; 79(6):428-30. PubMed ID: 11715437
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelial cancer and lack of relation to chemotherapy response and outcome.
    Sengeløv L; Christensen M; von der Maase HD; Horn T; Marcussen N; Kamby C; Orntoft T
    Cancer Genet Cytogenet; 2000 Dec; 123(2):109-13. PubMed ID: 11156735
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.
    Rashid A; Wang JS; Qian GS; Lu BX; Hamilton SR; Groopman JD
    Br J Cancer; 1999 Apr; 80(1-2):59-66. PubMed ID: 10389978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of Heterozygosity at Chromosome 16q Is a Negative Prognostic Factor in Korean Pediatric Patients with Favorable Histology Wilms Tumor: A Report of the Korean Pediatric Hematology Oncology Group (K-PHOG).
    Park JE; Noh OK; Lee Y; Choi HS; Han JW; Hahn SM; Lyu CJ; Lee JW; Yoo KH; Koo HH; Jeong SY; Sung KW
    Cancer Res Treat; 2020 Apr; 52(2):438-445. PubMed ID: 31505910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of heterozygosity at chromosome 13q in hepatocellular carcinoma: identification of three independent regions.
    Lin YW; Sheu JC; Liu LY; Chen CH; Lee HS; Huang GT; Wang JT; Lee PH; Lu FJ
    Eur J Cancer; 1999 Nov; 35(12):1730-4. PubMed ID: 10674021
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prognostic value of vascular endothelial growth factor in hepatocellular carcinoma for predicting metastasis after curative resection.
    Minata M; Harada KH; Kudo M; Ikai I; Nishida N
    Oncology; 2013; 84 Suppl 1():75-81. PubMed ID: 23428863
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Accumulation of genetic changes during development and progression of hepatocellular carcinoma: loss of heterozygosity of chromosome arm 1p occurs at an early stage of hepatocarcinogenesis.
    Kuroki T; Fujiwara Y; Tsuchiya E; Nakamori S; Imaoka S; Kanematsu T; Nakamura Y
    Genes Chromosomes Cancer; 1995 Jul; 13(3):163-7. PubMed ID: 7669735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Allelic imbalances and homozygous deletion on 8p23.2 for stepwise progression of hepatocarcinogenesis.
    Midorikawa Y; Yamamoto S; Tsuji S; Kamimura N; Ishikawa S; Igarashi H; Makuuchi M; Kokudo N; Sugimura H; Aburatani H
    Hepatology; 2009 Feb; 49(2):513-22. PubMed ID: 19105209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathological significance of loss of heterozygosity on chromosome 13q in hepatocellular carcinoma.
    Wong CM; Lee JM; Lau TC; Fan ST; Ng IO
    Clin Cancer Res; 2002 Jul; 8(7):2266-72. PubMed ID: 12114430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.
    Rosin MP; Cheng X; Poh C; Lam WL; Huang Y; Lovas J; Berean K; Epstein JB; Priddy R; Le ND; Zhang L
    Clin Cancer Res; 2000 Feb; 6(2):357-62. PubMed ID: 10690511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
    Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
    J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microsatellite Alterations With Allelic Loss at 9p24.2 Signify Less-Aggressive Colorectal Cancer Metastasis.
    Koi M; Garcia M; Choi C; Kim HR; Koike J; Hemmi H; Nagasaka T; Okugawa Y; Toiyama Y; Kitajima T; Imaoka H; Kusunoki M; Chen YH; Mukherjee B; Boland CR; Carethers JM
    Gastroenterology; 2016 Apr; 150(4):944-55. PubMed ID: 26752111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of chromosomal instability in pulmonary or liver metastases and matched primary hepatocellular carcinoma after orthotopic liver transplantation.
    Gross-Goupil M; Riou P; Emile JF; Saffroy R; Azoulay D; Lacherade I; Receveur A; Piatier-Tonneau D; Castaing D; Debuire B; Lemoine A
    Int J Cancer; 2003 May; 104(6):745-51. PubMed ID: 12640682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between microsatellite alterations on chromosome 8 and clinicopathological characteristics in hepatocellular carcinoma].
    Zhang SH; Cong WM; Xian ZH; Wu MC
    Zhonghua Bing Li Xue Za Zhi; 2004 Oct; 33(5):429-32. PubMed ID: 15498212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.